https://www.selleckchem.com/products/mk-8617.html
Death occurred at home for 23.1% (n=6) patients in follow-up by PHTs, 14.5% (n=1 patients in follow-up by HPCSTs, and 29.4% (n=53) patients in joint follow-up; 20.8% (n=46) were oncologic patients and 42.6% (n=23) were non-oncologic patients; 26.5% (n=63) had a main caregiver and 16.2% (n=6) didn't. Death occurred at home for 34.8% (n=31) of rural setting patients and for 20.4% (n=38) of urban setting patients (P0.007). Results support a higher percentage of deaths at home with joint follow-up. Results support a higher percentage
إعجاب
علق
شارك
